Latest News
Grand Opening of the 2025 Sustainable Global Leaders Conference: Kevin Kelly and the Turing Award Winner Share AI Frontiers, Business Leaders Discuss Sustainable Development
SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Approved by the State Council, the 2025 Sustainable Global Leaders Conference opened onOctober 16 in Huangpu District, Shanghai. Centered around the theme "Joining Hands to Address Challenges: Global Action, Innovation, and Sustainable Growth," the Conferen...
2025-10-20 10:20
1055
Redefines the Future of TV: SKYWORTH Unveils All-New Matte Screen Ultra TV Series at the 138th Canton Fair
SHENZHEN, China, Oct. 19, 2025 /PRNewswire/ -- From October 15 to 19, 2025, SKYWORTH showcased its all-new Matte Screen Ultra TV series, alongside a selection of standout TV products, at the 138th China Import and Export Fair (Canton Fair), highlighting its innovation and brand strength to v...
2025-10-20 09:56
1095
Xinhua Silk Road: Financial Street Forum annual conference to be held on Oct. 27-30 in Beijing
BEIJING, Oct. 19, 2025 /PRNewswire/ -- The annual conference of Financial Street Forum 2025 will be held onOctober 27-30 in Beijing. Over 400 delegates from more than 30 countries and regions will join the four-day conference, introduced by an official of the organizing committee of the forum at...
2025-10-20 09:35
1016
CARsgen Presents Preliminary Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025
SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the research results of the Phase Ib registrational clinical trial of satricabtagene autoleucel ("satri-cel", CT041)...
2025-10-20 08:15
1261
ESMO 2025: CStone Discloses Phase I Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)
SUZHOU, China, Oct. 19, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key disease areas, today announced the first disclosure...
2025-10-20 08:10
1095
Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances
SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd.
2025-10-20 07:00
1181
Significant OS Benefit with Cadonilimab in First-Line Advanced Gastric Cancer: Final Analysis of COMPASSION-15 Presented at ESMO 2025
HONG KONG, Oct. 19, 2025 /PRNewswire/ -- On October 19, 2025, Akeso (9926.HK) announced the final analysis results from the COMPASSION-15/AK104-302 study at the 2025 European Society of Medical Oncology Congress (ESMO 2025) . COMPASSION-15 is a Phase III clinical trial evaluating cadonilimab, Ak...
2025-10-19 23:42
1511
HARMONi-6 Data: mPFS 11.14 Months (HR=0.6, P<0.0001) Simultaneously Released at ESMO and in The Lancet
* Ivonescimab plus chemotherapy demonstrated a median PFS of 11.14 months, PFS HR=0.60, P < 0.0001. * The absolute difference in median PFS between the two groups was 4.24 months (ΔPFS = 4.24 months), indicating significantly prolonged progression-free survival with ivonescimab combination th...
2025-10-19 23:37
1374
United Imaging Marks Five Years Since the Opening of its Global Showroom In North America with a Record Number of U.S. Customer Visits
The company launched American R&D in 2013 and American commercial operations in 2018; in 2020 it opened a 100,000 square foot production and training center in Houston, and just tripled its local footprint to support strong growth. HOUSTON, Oct. 19, 2025 /PRNewswire/ -- United Imaging, a global m...
2025-10-19 22:00
1165
Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia
SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell malignancy, often associated with complex genetic abnormalities. There is currently no standard treatment regimens, and conventional therapies for multiple myeloma are typically...
2025-10-19 14:00
1604
China's Sichuan Extends Cultural Tourism Invitations at Global Landmarks
CHENGDU, China, Oct. 18, 2025 /PRNewswire/ -- According to Sichuan International Communication Center, onOctober 17 (Beijing time), the "Sichuan Ease" cultural tourism logo made its global debut simultaneously across five landmark locations worldwide, including Times Square inNew York, Westfield ...
2025-10-18 21:20
1692
Where Tech Meets Soul: CASEKOO Debuts 'Tribute to Artists' Series at West Bund Museum Art Store
LOS ANGELES, Oct. 17, 2025 /PRNewswire/ -- CASEKOO, the innovative tech accessories brand, announced its debut at the West Bund Museum Art Store with the launch of the "Tribute to Artists" series inShanghai, China. This exclusive collection marks a strategic entry into the art world, positioning ...
2025-10-18 05:00
1817
PINTEC's Subsidiary ZIITECH Makes Its Debut at Tech Week Singapore 2025
BEIJING, Oct. 17, 2025 /PRNewswire/ -- Pintec Technology Holdings Limited (Nasdaq: PT) ("PINTEC" or the "Company"), a leading technology platform committed to enabling innovative financial and digital solutions for businesses worldwide, today announced that its subsidiary ZIITECH PTY LTD ("ZIITEC...
2025-10-18 04:05
3270
LCY's Bowei Lee Calls for Reindustrialization to Reshape the Global Supply Chains for a More Resilient Future at Toronto Global Forum
TORONTO, Oct. 17, 2025 /PRNewswire/ -- Globalization is entering a different phase defined by strategic reindustrialization, weaponization of comparative advantages, as well as a reliable supply chain. At Toronto Global Forum,Bowei Lee, Chairman of LCY Group(LCY) calls for stronger collaboration ...
2025-10-18 03:00
2146
Multitude Therapeutics Announces Promising Interim Phase I/II Results from the Ongoing First-in-Human Study Evaluating its CD44v9-directed Antibody-Drug-Conjugate, AMT-116, in Heavily Pretreated EGFR Wild-type Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting
AMT-116 is a potential first-in-class CD44v9-directed Topoisomerase I inhibitor-based ADC AMT-116 demonstrated a favorable safety profile, with manageable hematologic and Gastrointestinal toxicities Promising efficacies were observed in patients with heavily pretreated EGFR Wild-type NSCLC and ...
2025-10-17 22:00
3529
JOYROOM PODIX 140W 5-Port GaN Charger Wraps Up Blockbuster Kickstarter Campaign with 6633% Funding Success
NEW YORK, Oct. 17, 2025 /PRNewswire/ -- JOYROOM, a global consumer electronics brand beloved by young users across more than 130 countries, announced today the successful completion of its Kickstarter campaign for the JOYROOM PODIX, the world's first Tri-Magnetic 140W 5-in-1 GaN Charging Station....
2025-10-17 22:00
1733
CLPS Incorporation Reports Financial Results for the Second Half and Full Year of Fiscal 2025
HONG KONG, Oct. 17, 2025 /PRNewswire/ -- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS), today announced its financial results for the six months and full year of fiscal 2025 ended June 30, 2025. During this fiscal year, we faced a significant challenge when our long-standing and hi...
2025-10-17 21:23
3420
Wired Magazine Founding Editor Kevin Kelly Visits Rokid Headquarters, Exploring the Future of AR and AI
HANGZHOU, China, Oct. 17, 2025 /PRNewswire/ -- Kevin Kelly, founding executive
editor of Wired magazine, visitedRokid
2025-10-17 21:00
1808
SparkRWA Expands AI Applications to Empower the Global Green Economy and Drive Sustainable Innovation
HONG KONG, Oct. 17, 2025 /PRNewswire/ -- GIBO Holdings Ltd. (NASDAQ: GIBO), Asia's leading innovation-driven creative ecosystem, today announced an extended application of its proprietary AI technologies under theSparkRWA Green Creator Framework, marking a major step toward integrating artificial...
2025-10-17 20:43
1866
Re-imagining Neo-Pragmatic Lifestyle: EPWK Launches Strategic Upgrade with "EPWK Curated Goods"
XIAMEN, China, Oct. 17, 2025 /PRNewswire/ -- "We grew weary of life's monotony, so we embarked on a journey to find 'EPWK Curated Goods.' Each selected item must pass our stringent 'Three Goods' standard: Good-looking, Good-to-use, and Good-surprise. We believe that truly excellent products can i...
2025-10-17 20:36
1448
Week's Top Stories
Most Reposted
One Universal Production Group (OUP) Officially Opens, Reinforcing Its Position as Asia's Leading IP Ecosystem and Tourism Company
[Picked up by 313 media titles]
2025-12-20 09:36
Singapore Airshow 2026 Marks 10th Edition with New Frontiers in Aviation and Space
[Picked up by 308 media titles]
2025-12-18 19:41
foodpanda Strengthens Merchant Care with Record Onboarding Milestone in Asia
[Picked up by 292 media titles]
2025-12-18 17:15Commanding Accolades: Peach Blossoms and Executive Chinese Chef Edward Chong Honoured by Multiple International Award Wins
[Picked up by 287 media titles]
2025-12-18 17:43
Rosewood Hotel Group Accelerates Global Expansion with On-Track 2025 Openings; Entering New Sector with Its First-Ever Ski Resort
[Picked up by 287 media titles]
2025-12-19 14:40
Most Read
Cognizant and Microsoft Expand Partnership to Advance AI Transformation and Frontier Firm Experiences
2025-12-18 22:00
6230
